907945-62-4

Basic information

• Product Name: ETHYL 6-BROMOBENZOFURAN-2-CARBOXYLATE
• Synonyms: ETHYL 6-BROMOBENZOFURAN-2-CARBOXYLATE;Ethyl6-bromo-1-benzofuran-2-carboxylate;6-Bromo-2-benzofurancarboxylic acid ethyl ester
• CAS NO: 907945-62-4
• Molecular Formula: C₁₁H₉BrO₃
• Molecular Weight: 269.1
• Mol File: 907945-62-4.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: ETHYL 6-BROMOBENZOFURAN-2-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 6-BROMOBENZOFURAN-2-CARBOXYLATE(907945-62-4)
• EPA Substance Registry System: ETHYL 6-BROMOBENZOFURAN-2-CARBOXYLATE(907945-62-4)

Safety Data

• Hazardous Substances Data: 907945-62-4(Hazardous Substances Data)

Usage

General Description

ETHYL 6-BROMOBENZOFURAN-2-CARBOXYLATE is an organic compound with the molecular formula C13H9BrO3. It belongs to the class of benzofuran derivatives and is used in the synthesis of pharmaceuticals and agrochemicals. This chemical is commonly used as an intermediate or building block in the production of various drugs and other organic compounds. It is also used in research and development activities in the pharmaceutical and chemical industries.ETHYL 6-BROMOBENZOFURAN-2-CARBOXYLATE is a versatile and important chemical that serves as a key component in the synthesis of various organic compounds.

Upstream product

• 22532-62-3 4-bromosalicylaldehyde 
• 105-36-2 ethyl bromoacetate 
• 105-39-5 chloroacetic acid ethyl ester 

Downstream Products

• 1089681-53-7 4-[(1E)-2-(6-bromo-1-benzofuran-2-yl)ethenyl]-N,N-dimethylbenzenamine 
• 1089681-55-9 4-[(1E)-2-(6-iodo-1-benzofuran-2-yl)ethenyl]-N,N-dimethylbenzenamine 

Relevant articles and documents

HDAC inhibitor and preparation method and application thereof

The present invention discloses a compound represented by a formula I, a stereoisomer thereof, and a pharmaceutically acceptable salt thereof. The invention further relates to a pharmaceutical composition containing the compound shown in the formula I and application of the compound in preparation of HDAC inhibitor drugs. The compound or the pharmaceutical composition thereof can be used for treating cell proliferation diseases, autoimmune diseases, inflammation, neurodegenerative diseases or viral diseases.

CATHEPSIN K INHIBITOR AND APPLICATION THEREOF

The invention relates to capthepsin K inhibitors and uses thereof, specifically relates to a class of compounds having the formula (I) which are used for treating or preventing cathepsin dependent diseases or conditions, specifically, wherein the cathepsin is capthepsin K. The compounds and compositions thereof can be used as bone resorption inhibitors for the treatment of associated diseases.

2'-carbonyl-3-bromo-spiro[benzofuran-2,4'-oxazolidine] compounds and preparation method thereof

The invention discloses 2'-carbonyl-3-bromo-spiro[benzofuran-2, 4'-oxazolidine] compounds and a preparation method thereof. The 2'-carbonyl-3-bromo-spiro[benzofuran-2,4'-oxazolidine] compounds are photoactive compounds shown in the structural formula II. The 2'-carbonyl-3-bromo-spiro[benzofuran-2,4'-oxazolidine] compounds are photoactive spiro compounds, photoactive chiral spiro compounds with multiple functional groups substituted, such as photoactive chiral spiro compounds with azido groups, hydroxyl groups, allyl groups and anisole groups substituted, can be obtained through substitution reactions of bromine atoms at site 3 under different reaction conditions. Therefore, different kinds of other photoactive chiral spiro compounds are prepared by using the substitution reactions of bromine atoms, the range of the compounds is enlarged, and the potential application value is great.